Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know

Pfizer has been heavily searched on Zacks.com lately. The stock returned +0.6% over the past month, underperforming the S&P 500's +1.3% gain. Pfizer holds a Zacks Rank #2 (Buy) rating based on earnings estimate revisions and other factors. The company is expected to report declining earnings year-over-year but has consistently beaten consensus estimates in recent quarters. Pfizer trades at a valuation discount to peers with a B grade on the Value Style Score.